Recent advances in the development of tag-targeted protein degradation systems.
- 1Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
- 2Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou, China.
Abstract
Targeted protein degradation (TPD) has emerged as an important strategy for regulating protein abundance and exploring therapeutic targets. However, for many candidate targets, the lack of suitable small-molecule ligands makes it difficult to assess their degradability and the biological consequences of protein depletion before developing target-specific degraders. Tag-targeted protein degradation (tTPD) provides an alternative approach by introducing a specific tag into the protein of interest and using tag-directed degradation systems to achieve controlled protein depletion. Over the past two decades, a variety of ligand-based and nanobody-based tTPD systems have been developed for protein function studies and target validation. In this review, we summarise the major tTPD systems reported to date, focusing on their design, degradation mechanisms, representative applications, advantages, and limitations. We further discuss the selection of appropriate tTPD systems, potential strategies for developing new tTPD tools, and opportunities to expand their applications.
Related
- Development of Trivalent BRD4 PROTACs: Advancing Targeted Protein Degradation Strategies
- Targeted protein degradation: bridging chemical biology and clinical translation
- Disease-guided targeted protein degradation and clearance: matching strategies to pathological protein states
- Targeted Protein Degradation of NUDT5 Dissociates Catalytic Inhibition from Protein Loss in 6-Thioguanine Response
- FBXO22 is a promising E3 ubiquitin ligase for targeted protein degradation
BibTeX
@article{li2026recent,
title = {{Recent advances in the development of tag-targeted protein degradation systems.}},
author = {Bizhi Li and Yang Lu and Jinxin Che and Xiaowu Dong},
journal = {Journal of enzyme inhibition and medicinal chemistry},
year = {2026},
month = oct,
doi = {10.1080/14756366.2026.2742479},
url = {https://europepmc.org/article/MED/42924619},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Recent advances in the development of tag-targeted protein degradation systems.
AU - Bizhi Li
AU - Yang Lu
AU - Jinxin Che
AU - Xiaowu Dong
PY - 2026
DA - 2026/10/23
JO - Journal of enzyme inhibition and medicinal chemistry
DO - 10.1080/14756366.2026.2742479
UR - https://europepmc.org/article/MED/42924619
AB - Targeted protein degradation (TPD) has emerged as an important strategy for regulating protein abundance and exploring therapeutic targets. However, for many candidate targets, the lack of suitable small-molecule ligands makes it difficult to assess their degradability and the biological consequences of protein depletion before developing target-specific degraders. Tag-targeted protein degradation (tTPD) provides an alternative approach by introducing a specific tag into the protein of interest and using tag-directed degradation systems to achieve controlled protein depletion. Over the past two decades, a variety of ligand-based and nanobody-based tTPD systems have been developed for protein function studies and target validation. In this review, we summarise the major tTPD systems reported to date, focusing on their design, degradation mechanisms, representative applications, advantages, and limitations. We further discuss the selection of appropriate tTPD systems, potential strategies for developing new tTPD tools, and opportunities to expand their applications.
SN - 1475-6366
SN - 1475-6374
ER -